Knowledge dynamics: Biotechnology's incursion into the pharmaceutical industry

Industry and Innovation

Volumn 10, Issue 3, 2003, Pages 255-273

  Quéré, Michel ^a  

^a CNRS Latapses   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; HIGH TECHNOLOGY INDUSTRY; PHARMACEUTICAL INDUSTRY; TECHNOLOGICAL DEVELOPMENT;

BIOTECHNOLOGY; DRUG INDUSTRY; RECOMBINANT DNA TECHNOLOGY; TECHNOLOGY;

EID: 0345359592     PISSN: 13662716     EISSN: None     Source Type: Journal    
DOI: 10.1080/1366271032000141643     Document Type: Article

References (41)

1. Achilladelis, B. and Antonakis, N. 2001: The dynamics of technological innovation: the case of the pharmaceutical industry, Research Policy, 30: 535-588.
2. Bud, R. 1993: The Uses of Life, an History of Biotechnology. Cambridge: Cambridge University Press.
3. Bud, R. 1998: Molecular biology and the long-term history of biotechnology, in A. Thackray (ed.), Private Science. Philadelphia: University of Pennsylvania Press.
4. Coase, R. 1937: The nature of the firm, Economica, 4: 386-405.
5. Cockburn, I.M., Henderson, R. and Stern, S. 1999: The diffusion of science-driven drug discovery: organisational change in pharmaceutical research. NBER Working Paper No. 7359, September.
6. Cohen, M. and Levinthal, D. 1990: Absorptive capacity: a new perspective on learning and innovation, Administrative Science Quarterly, 35: 128-152.
7. Coriat, B. and Orsi, F. 2002: Establishing a new intellectual property rights regime in the United States. Origins, contents, problems, Research Policy, No. 7/8: 1491-1507.
8. Coriat, B., Orsi, F. and Weinstein, O. 2003: Does biotech reflect a new science-based innovation regime?, Industry and Innovation (this issue).
9. De la Mothe, J. and Niosi, J. 2000: The Economic and Social Dynamics of Biotechnology. Boston: Kluwer Academic Press.
10. Dibner, M. 1999: Biotechnology Guide USA-Companies, Data and Analysis. Basingstoke: Macmillan.
11. ìeme conception d'une théorie de la firme [Edith Penrose, or the 22nd conception of a theory of the firm], Economie et Société, série Oeconomia, 29(8): 187-205.
12. Foss, N.J. 1997: Resources, Firms and Strategies-a Reader in the Resource-based Perspective. Oxford: Oxford University Press.
13. Foss, N.J. and Knudsen, C. 1996: Towards a Competence Theory of the Firm. London and New York: Routledge.
14. Foss, N.J. and Loasby, B. 1998: Economic Organisation, Capabilities and Co-ordination: Essays in Honour of G.B. Richardson. London and New York: Routledge.
15. Fransman, M. 1994: Information, knowledge, vision and theory of the firm, Industrial and Corporate Change, 3(3): 713-758.
16. Galambos, L. and Sturchio, J. 1998: Pharmaceutical firms and the transition to biotechnology: a study in strategic innovation, Business History Review, 72(2): 250-278.
17. Gibbons, M., Limoges, C., Nowotny, H., Schwarztman, S., Scott, P. and Trow, M. 1994: The New Production of Knowledge: The Dynamics of Science and Research in Contemporary Societies. London: Sage.
18. Grabowski, H. and Vernon, J. 1994: Innovation and structural change in pharmaceuticals and biotechnology, Industrial and Corporate Change, 3(3): 435-450.
19. Hoch, H.C., Jelinski, L.W. and Caighead, H.G. 1996: Nanofabrication and Biosystems: Integrating Materials Science, Engineering, and Biology. Cambridge: Cambridge University Press.
20. Kenney, M. 1998: Biotechnology and the creation of a new economic space, in A. Thackray (ed.), Private Science. Philadelphia: University of Pennsylvania Press.
21. Malloy, M. 1999: Mergers and acquisition in biotechnology, Nature-Biotechnology, 17(May): 11-12.
22. McKelvey, M. 1996: Evolutionary Innovations: The Business of Biotechnology. Oxford: Oxford University Press.
23. McKelvey, M. and Orsenigo, L. 2001: Pharmaceuticals as a sectoral innovation system. ESSY Project-Working Paper, November, mimeo.
24. Mowery, D.C. and Sampat, B.N. 2001: University patents and patent policy debates in the USA, 1925-1980, Industrial and Corporate Change, 10(3): 781-814.
25. Oliver, R.W. 1999: The Coming Biotech-Age. New York: McGraw-Hill.
26. Orsenigo, L., Pamolli, F. and Riccaboni, M. 2001: Technological change and network dynamics: lessons from the pharmaceutical industry, Research Policy, 30: 485-508.
27. Ostro, M.J. and Esposito, R.S. 1999: A rationale for consolidation among biotechnology microcaps, Nature-Biotechnology, 17(May): 16-17.
28. Penrose, E. 1959/1995: The Theory of the Growth of the Firm, 1st/3rd edn. New York: John Wiley.
29. Pitelis, C. 2001: The Growth of the Firm: the Legacy of Edith Penrose. Oxford: Oxford University Press.
30. Powell, W.W., Koput, K.W. and Smith-Doerr, L. 1996: Interorganizational collaboration and the locus of innovation: networks of learning in biotechnology, Administrative Science Quarterly, 41(1): 116-145.
31. Pyka, A. and Saviotti, P. 2001: Networking in biotechnology industries-from translators to explorers. SEIN Project Working Paper.
32. Quéré, M. 2002: The post-genome era: continuity or rupture in the organisation of the life sciences industry, contribution to the Workshop "The Economics and Business of Bio-Sciences & Bio-Technologies: What can be Learnt from the Nordic Countries and the UK?", Gothenburg, 25-27 September.
33. Quéré, M. and Saviotti, P.P. 2002: Knowledge dynamics and the organisation of the life science industries, DRUID Summer Conference on "Industrial Dynamics of the New and Old Economy-Who is Embracing Whom?", Copenhagen, 6-8 June.
34. Rashidi, H.H. and Buehler, L.K. 2000: Bioinformatics Basics, Applications in Biological Science and Medicine. London: CRC Press.
35. Richardson, G.B. 1972: The organization of industry, Economic Journal, 82: 883-896.
36. Richardson, G.B. 1975: Adam Smith on competition and increasing returns, in A.S. Skinner and T. Wilson (eds.), Essays on Adam Smith. Oxford: Clarendon Press.
37. Richardson, G.B. 1998: The Economics of Imperfect Knowledge. Cheltenham: Edward Edgar.
38. Robbins-Roth, C. 2000: From Alchemy to IPO: the Business of Biotechnology. Cambridge, MA: Perseus.
39. Saviotti, P. 1998: Industrial structure and the dynamics of knowledge generation in biotechnology, in J. Senker and R. van Vliet (eds.). Biotechnology and Competitive Advantage, Europe's Firms and the US Challenge. Cheltenham: Edward Edgar.
40. Saviotti, P.P., de Looze, M.-A., Michelland, S. and Catherine, D. 2000: The changing marketplace of bioinformatics, Nature-Biotechnology 18(12): 1247-1249.
41. Senker, J., Joly, P.B. and Reinhard, M. 1998: Biotechnology and Europe's chemical/pharmaceutical multinationals, in J. Senker and R. van Vliet (eds.), Biotechnology and Competitive Advantage, Europe's Firms and the US Challenge. Cheltenham: Edward Edgar.